Skip to main content
. 2017 Mar 8;2(5):498–505. doi: 10.1001/jamacardio.2016.5977

Table 3. Clinical Outcomes Between the Preimplementation and Postimplementation Phases Stratified by Hub Hospitals and Spoke Health Centers.

Outcome Hub Hospitals, No. (%)
(n = 1367)
Spoke Health Centers, No. (%)
(n = 1053)
Overall, No. (%) P Value
Preimplementation Phase
(n = 413)
Postimplementation Phase
(n = 954)
Preimplementation Phase
(n = 485)
Postimplementation Phase
(n = 568)
Preimplementation Phase
(n = 898)
Postimplementation Phase
(n = 1522)
In-hospital mortality (n = 2420) 15 (3.6) 49 (5.1) 37 (7.6) 36 (6.3) 52 (5.8) 85 (5.6) .83
Stroke (n = 2420) 1 (0.2) 1 (0.1) 3 (0.6) 2 (0.4) 4 (0.5) 3 (0.2) .27
Cardiogenic shock (n = 2420) 8 (1.9) 23 (2.4) 27 (5.6) 26 (4.6) 35 (3.9) 49 (3.2) .38
Symptomatic ischemia (n = 2420) 1 (0.2) 6 (0.6) 15 (3.1) 10 (1.8) 16 (1.8) 16 (1.1) .13
1-Year mortality (n = 2020) 48 (13.3) 100 (12.1) 86 (21.5) 79 (18.2) 134 (17.6) 179 (14.2) .04